Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Ovarian Neoplasms 4Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Venous Thromboembolism 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Cancer Prevention 1

Interventions

Carboplatin 159Paclitaxel 153Bevacizumab 85Taxes 48Gemcitabine 48liposomal doxorubicin 47Topotecan 41Cisplatin 35pembrolizumab 33Cyclophosphamide 28olaparib 25Immunoglobulin G 24Disulfides 24Specimen Handling 21Drug Therapy 20Docetaxel 20niraparib 18Magnetic Resonance Spectroscopy 18Doxorubicin 17Biopsy 15mirvetuximab soravtansine 14Hyperthermic Intraperitoneal Chemotherapy 14rucaparib 13Nivolumab 12Cytoreduction Surgical Procedures 11Chemotherapy, Adjuvant 10Albumin-Bound Paclitaxel 10veliparib 9Platinum 9Neoadjuvant Therapy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Aspirin × Gynecologic × Clear all
NCT05080946 2026-04-01

Using Aspirin to Improve Immunological Features of Ovarian Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Recruiting
100 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03771651 2026-02-17

Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

University of Oklahoma

Phase EARLY_PHASE1 Active not recruiting
18 enrolled
Gynecologic

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡